stockrowAmgen Inc.
AMGN Healthcare Drug Manufacturers General
Amgen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $36.8 billion, up 9.95% from fiscal 2024.
- Revenue
- +8.45%
- EPS
- +19.4%
- Free cash flow
- −0.16%
- Total debt
- −1.06%
Quarter to September 2026, against a year earlier
Follow AMGN
Alert me
Amgen Inc. (AMGN) Operating margin
Amgen Inc.'s operating margin over the twelve months to 30 September 2026 was 32.4%, up 7.7 percentage points from fiscal 2025 (24.7%). Over the past ten years it has ranged from 21.7% (fiscal 2024) to 43.7% (fiscal 2017); the current reading is higher than 18% of that period. That is above the Drug Manufacturers General industry median of 18.3% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 24.7% | 3.00 |
| FY2024 | 21.7% | (6.30) |
| FY2023 | 28.0% | (8.33) |
| FY2022 | 36.3% | 6.94 |
| FY2021 | 29.4% | (6.55) |
| FY2020 | 36.0% | (5.46) |
| FY2019 | 41.4% | (1.81) |
| FY2018 | 43.2% | (0.43) |
| FY2017 | 43.7% | 1.05 |
| FY2016 | 42.6% | 3.50 |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Sep 2026 | 35.8% | 0.84 |
| Jun 2026 | 35.0% | 4.01 |
| Mar 2026 | 30.9% | 3.37 |
| Dec 2025 | 27.6% | 1.14 |
| 43 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| NVO Novo Nordisk A/S compare | 43.4% |
| AMGN Amgen Inc. | 32.4% |
| ABBV AbbVie Inc. compare | 32.2% |
| NVS Novartis AG compare | 25.2% |
| AZN AstraZeneca PLC compare | 23.7% |
| BMY Bristol Myers Squibb Company compare | 22.7% |
| PFE Pfizer Inc. compare | 21.4% |
| MRK Merck & Co., Inc. compare | 9.20% |
| GILD Gilead Sciences, Inc. compare | −7.63% |
| Drug Manufacturers General industry median | 18.3% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on AMGN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement